Cargando…
Alpha-Synuclein and Cognitive Decline in Parkinson Disease
Parkinson disease (PD) is the second most common neurodegenerative disorder in elderly people. It is characterized by the aggregation of misfolded alpha-synuclein throughout the nervous system. Aside from cardinal motor symptoms, cognitive impairment is one of the most disabling non-motor symptoms t...
Autores principales: | Fan, Tian-Sin, Liu, Sam Chi-Hao, Wu, Ruey-Meei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625417/ https://www.ncbi.nlm.nih.gov/pubmed/34833115 http://dx.doi.org/10.3390/life11111239 |
Ejemplares similares
-
Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017) -
The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways
por: Kuo, Ming-Che, et al.
Publicado: (2021) -
Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson’s Disease
por: Folke, Jonas, et al.
Publicado: (2022) -
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015) -
The Identification of Alpha-Synuclein as the First Parkinson Disease Gene
por: Nussbaum, Robert L.
Publicado: (2017)